Bossé Janine T, Soares-Bazzolli Denise M, Li Yanwen, Wren Brendan W, Tucker Alexander W, Maskell Duncan J, Rycroft Andrew N, Langford Paul R
Section of Paediatrics, Imperial College London, St Mary's Campus, London, United Kingdom.
Section of Paediatrics, Imperial College London, St Mary's Campus, London, United Kingdom; Laboratório de Genética Molecular de Micro-organismos, Departamento de Microbiologia - DMB - BIOAGRO, Universidade Federal de Viçosa - Viçosa, Brazil.
PLoS One. 2014 Nov 19;9(11):e111252. doi: 10.1371/journal.pone.0111252. eCollection 2014.
We have developed a simple method of generating scarless, unmarked mutations in Actinobacillus pleuropneumoniae by exploiting the ability of this bacterium to undergo natural transformation, and with no need to introduce plasmids encoding recombinases or resolvases. This method involves two successive rounds of natural transformation using linear DNA: the first introduces a cassette carrying cat (which allows selection by chloramphenicol) and sacB (which allows counter-selection using sucrose) flanked by sequences to either side of the target gene; the second transformation utilises the flanking sequences ligated directly to each other in order to remove the cat-sacB cassette. In order to ensure efficient uptake of the target DNA during transformation, A. pleuropneumoniae uptake sequences are added into the constructs used in both rounds of transformation. This method can be used to generate multiple successive deletions and can also be used to introduce targeted point mutations or insertions of heterologous genes into the A. pleuropneumoniae chromosome for development of live attenuated vaccine strains. So far, we have applied this method to highly transformable isolates of serovars 8 (MIDG2331), which is the most prevalent in the UK, and 15 (HS143). By screening clinical isolates of other serovars, it should be possible to identify other amenable strains.
我们开发了一种简单的方法,利用胸膜肺炎放线杆菌进行自然转化的能力,在该细菌中产生无疤痕、无标记的突变,且无需引入编码重组酶或解离酶的质粒。该方法涉及使用线性DNA进行两轮连续的自然转化:第一轮引入一个携带cat(用于氯霉素选择)和sacB(用于蔗糖反向选择)的盒式结构,其两侧为靶基因两侧的序列;第二轮转化利用直接相互连接的侧翼序列以去除cat-sacB盒式结构。为了确保转化过程中靶DNA的有效摄取,将胸膜肺炎放线杆菌摄取序列添加到两轮转化中使用的构建体中。该方法可用于产生多个连续缺失,也可用于将靶向点突变或异源基因插入胸膜肺炎放线杆菌染色体中,以开发减毒活疫苗株。到目前为止,我们已将此方法应用于血清型8(MIDG2331,在英国最为普遍)和15(HS143)的高度可转化分离株。通过筛选其他血清型的临床分离株,应该有可能鉴定出其他合适的菌株。